{"title":"General Pharmacology","description":null,"products":[{"product_id":"biotechnological-innovation-and-sustainable-developmental-goals-fostering-good-health-and-wellbeing","title":"Biotechnological Innovation and Sustainable Developmental Goals: Fostering Good Health and Wellbeing","description":"\u003cp\u003eby RC Sobti (ed.) This reference book examines the role of biotechnological innovations in achieving global health targets, addressing disease burdens, and fostering a sustainable healthcare ecosystem for promoting good health and wellbeing. It covers a wide range of topics including the evolution of healthcare technologies, epidemiological approaches in predictive medicine, management of diseases across different organs, emerging technologies in drug development, design, and delivery systems, vaccination strategies; technologies for tackling pandemics; and biotechnological applications in regenerative medicine and tissue engineering. Further, the book discusses different biotechnological advances in geriatric medicine and innovative therapies for age-related diseases. It also explores the intersection of biotechnology with maternal and child health and emphasizes the One Health approach in preventing and controlling zoonotic diseases. This book is intended for researchers, academics, and professionals in biotechnology, healthcare, and public health. Key Features Discusses the potential of biotechnological innovations in achieving sustainable development goals towards good health and wellbeing Provides an in-depth analysis of the latest biotechnological innovations in pharmaceuticals, diagnostics, medical devices, regenerative medicine, and personalized medicine Examines the role of biotechnology in addressing major global health challenges, such as infectious diseases, non-communicable diseases, and maternal and child health Reviews biotechnological advances in geriatric medicine, age-related diseases, longevity, anti-aging biotechnologies, and innovative drug delivery systems Presents the vast potential of biotechnological applications in regenerative medicine and tissue engineering Assesses ethical, legal, and social implications of biotechnological advancements in healthcare and their impact on individuals, societies, and sustainable development\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537472336113,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040378946.jpg?v=1786384491"},{"product_id":"pharmaceutical-microemulsions-for-parenteral-delivery-from-bench-to-bedside","title":"Pharmaceutical Microemulsions for Parenteral Delivery: From Bench to Bedside","description":"\u003cp\u003eby Vivek P. Chavda (ed.), Vandana B. Patravale (ed.) Parenteral delivery of hydrophobic drugs is a challenging task. Research on exploiting newer approaches to make the delivery of pharmaceuticals by nondigestive tracts effective yet safe and cost effective shows that microemulsion is one such approach for parenteral delivery. This new book provides systematic information regarding the preformulation of drugs, formulation using quality by design (QbD) principles, and characterization of parenteral microemulsions for drug delivery. The book explores specific aspects of microemulsions such as the role of surfactants and cosurfactants in formulation, clinical aspects of parenteral microemulsion, regulatory perspectives and patents, as well as future challenges in this field of research.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537473024241,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040095676-1.jpg?v=1786384492"},{"product_id":"pharmacological-targets-in-metabolic-diseases-challenges-and-opportunities","title":"Pharmacological Targets in Metabolic Diseases: Challenges and Opportunities","description":"\u003cp\u003eby Marcos Roberto de Oliveira PhD (ed.) Pharmacological Targets in Metabolic Diseases: Challenges and Opportunities is a complete reference on possible drug development targets to be leveraged in therapeutic developments. Covering both signaling pathways and specific proteins, the book presents ways to modulate the molecular and cellular alterations observed in metabolic diseases and disorders through the application of new or classical drugs. The comprehensive coverage starts by providing an overview of metabolic diseases and disorders, biological alterations, and pharmacological targets. This section covers targets at both molecular, and subcellular and cellular levels. The next section in the book is focused on pharmaceutical targeting of organs, including a dedicated chapter to the gut-brain axis. Next comes a thorough review of the current advances in metabolic syndrome research. Section VI is focused on inborn errors of metabolism and is followed by a section devoted to natural molecules and their pharmacological potential to treat these conditions. The Editor introduces next a whole section dedicated to the role of the microbiota in metabolic diseases therapeutics. The following sections cover the impact of aging, nanotechnology, the environment, and finally diagnostic techniques in metabolic diseases and disorders. Pharmacological Targets in Metabolic Diseases: Challenges and Opportunities meet the needs of pharmacology researchers looking for a comprehensive and authoritative source of information on possible therapeutic targets to treat these conditions. Research physicians, nutritionists, pharmacists, and biologists can benefit from the detailed information provided at the different levels of targets identified to treat metabolic diseases and conditions. - Covers the most prevalent metabolic diseases and disorders such as metabolic syndrome, diabetes mellitus (types I and II) and dyslipidemia, among others - Includes chapters on the microbiome and environmental pollution as they relate to metabolic diseases and conditions - Discusses cellular structures like the endoplasmic reticulum and mitochondria as pharmacological targets\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537474302193,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443273711.jpg?v=1786384495"},{"product_id":"perinatal-psychopharmacology-2025th-edition","title":"Perinatal Psychopharmacology, 2025th Edition","description":"\u003cp\u003eby Faruk Uguz (ed.), Laura Orsolini (ed.) This fully revised second edition presents up-to-date information on currently available scientific evidence, expert opinions, and practical recommendations on the use of psychotropic drugs, as well as pharmacological and biological treatments in the field of perinatal psychiatry. In addition to the social context, many women experience the occurrence or recurrence of psychiatric disorders during the perinatal period. Psychiatric disorders during this period can have negative effects on the fetus, infant, and other children in the family, and can result in functional impairment in mothers. The book offers a comprehensive overview of psychopharmacological treatments for nearly all specific psychiatric conditions and includes, besides chapters on antidepressants, antipsychotics, mood stabilizers, benzodiazepines, and Z-drugs, a new chapter on other available drugs. An additional chapter discusses electroconvulsive therapy and other biological therapies. In the last chapter, the psychopharmacologic treatment of hyperemesis gravidarum is described. The book will appeal to a wide readership, including psychiatrists, obstetricians, gynecologists, and paediatricians.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537475416305,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9783031997198.jpg?v=1786384498"},{"product_id":"innovations-in-drug-manufacturing-fdm-3d-printing-for-pharmaceuticals","title":"Innovations in Drug Manufacturing: FDM 3D Printing for Pharmaceuticals","description":"\u003cp\u003eby Kuldeep Vinchurkar (ed.), Sheetal Mane (ed.) This book offers a comprehensive insight into the application of Fused Deposition Modeling (FDM)—a cutting-edge 3D printing technology—in pharmaceutical manufacturing. As personalized medicine and precision drug delivery gain momentum, FDM emerges as a transformative tool for designing patient-specific dosage forms with enhanced efficiency and control. The book explores the core principles of FDM and its integration into pharmaceutical processes, from formulation to final product development. It addresses critical challenges, regulatory considerations, and real-world solutions for implementing FDM in a GMP-compliant environment. Tailored for students, researchers, industry professionals, and healthcare innovators, this book combines foundational knowledge with advanced applications. It includes case studies, recent technological advances, and expert perspectives, enabling readers to grasp both the scientific and practical aspects of FDM-based pharmaceutical manufacturing.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537475711217,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9789819690749.jpg?v=1786384499"},{"product_id":"leadership-for-pharmacists-moving-towards-strategic-roles-in-the-pharmaceutical-industry","title":"Leadership for Pharmacists: Moving Towards Strategic Roles in the Pharmaceutical Industry","description":"\u003cp\u003eby Nsovo Mayimele This book provides a toolkit of leadership skills for pharmacists wishing to take more strategic roles within the pharmaceutical industry, outlining a range of ten competencies through which their existing technical knowledge can be elevated to offer managerial as well as pharmaceutical expertise. Written in response to the lack of pharmacists in leading roles within the pharmaceutical industry, each chapter explores a different leadership skill, and how these can be applied. The skills include emotional intelligence, teamwork, integrity, selfless service, communication and relationship management. Supported by interviews with senior figures within the pharmaceutical industry, this book suggests that pharmacists themselves have the capacity to play an important, progressive role in leading these organisations and improving patient care. This book will interest students and researchers of pharmacy, leadership and industry studies, as well as pharmacists practising today.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537476268273,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040423233-1.jpg?v=1786384500"},{"product_id":"immunotherapy-in-autoimmune-disorders-mechanisms-and-applications","title":"Immunotherapy in Autoimmune Disorders: Mechanisms and Applications","description":"\u003cp\u003eby Javed Naim Agrewala (ed.) This book offers a comprehensive review of the molecular and cellular mechanisms underlying autoimmune disorders, as well as the role of immunotherapy in managing these diseases. The initial chapter introduces the concept of tolerance, the immune system's capacity to distinguish between self and non-self. Further, it explores various factors that can disrupt this balance, leading to a breakdown of tolerance and the onset of autoimmune diseases. The book evaluates current strategies for managing autoimmune diseases, emphasizes their limitations, and introduces immunotherapeutic approaches. Furthermore, it delves into the latest advancements in immunosuppression, vaccine development, and the role of specific immune cells in autoimmune conditions. It discusses the generation of regulatory T cells (Tregs) and their therapeutic potential, as well as examines vaccines and myeloid-derived suppressor cells for preventing and treating autoimmune diseases. Additionally, the book addresses a revolutionary approach, chimeric antigen receptor T-cell (CART) therapy, for treating autoimmune disorders. Toward the end, the book examines the role of the gut microbiome on immune function and autoimmunity. It considers innovative drug delivery strategies as the future of personalized medicine in managing autoimmune diseases. This book is a valuable resource for researchers and students in immunology, microbiology, and pharmaceutical sciences. Key Features Explores promising new frontiers in next-generation immunotherapy for autoimmune diseases Reviews the role of factors leading to the loss of immune tolerance and existing autoimmune disease management Examines innovative drug delivery strategies and the therapeutic potential of nutraceuticals against autoimmune diseases Reviews the role and therapeutic potential of gut microbiome in autoimmune disorders Presents the therapeutic potential of Tregs, chimeric antigen receptor T-cell therapy, and myeloid-derived suppressor cells in treating autoimmune diseases\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537476759793,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781032851952.jpg?v=1786384501"},{"product_id":"artificial-intelligence-in-precision-drug-design-volume-1-foundations-and-core-techniques","title":"Artificial Intelligence in Precision Drug Design, Volume 1: Foundations and Core Techniques","description":"\u003cp\u003eby Khalid Raza MCA, MPhil and PhD (ed.) Artificial Intelligence in Precision Drug Design: Advanced Applications showcases how artificial intelligence (AI) is revolutionizing modern drug discovery and development. Building upon the foundational principles established in Volume 1, this book dives into real-world applications where AI accelerates innovation, enhances predictive accuracy, and enables breakthrough therapeutics. Featuring contributions from leading global researchers and practitioners, the book explores machine learning, deep learning, and network-based approaches applied to complex biomedical challenges. Key areas include AI driven drug repurposing, combination therapies, immunotherapy, vaccine design, quantum computing, and the integration of large language models in drug discovery. Additional chapters highlight predictive modeling using electronic health records, AI-powered medical imaging, and explainable AI for structure-based drug design. What sets this volume apart is its emphasis on practical impact, demonstrating how data, computation, and interdisciplinary collaboration converge to advance precision medicine. Designed for scientists, clinicians, educators, and students, it serves as both a comprehensive reference and a source of inspiration for leveraging AI to transform healthcare.• Focuses on real-world AI applications in drug design and development provides comprehensive coverage of advanced techniques: deep learning, network-based models, and quantum computing.• Includes case studies on drug repurposing, combination therapies, immunotherapy, and vaccine development.• Provides insights into predictive modeling, AI-driven medical imaging, and explainable AI.• Highlights practical impact and interdisciplinary collaboration in precision medicine.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537477251313,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443444166.jpg?v=1786384503"},{"product_id":"innovations-in-drug-discovery-exploring-cutting-edge-strategies-and-technologies","title":"Innovations in Drug Discovery: Exploring Cutting-Edge Strategies and Technologies","description":"\u003cp\u003eby Krishnaveni Manubolu (ed.), Raveesha Peeriga (ed.) This fascinating volume delves into the forefront of pharmaceutical research to shed light on the ground-breaking methodologies and technologies driving advancements in drug discovery today. Providing a comprehensive overview of emerging trends and new approaches, it covers the entire drug discovery process, from target identification to clinical development, providing readers with a holistic understanding of the field. Each chapter outlines a different approach, from computational methods and high-throughput screening techniques to the application of artificial intelligence and machine learning in drug design. Additionally, it explores the integration of genomic, proteomic, and metabolomic data in target identification and validation processes, as well as the utilization of CRISPR\/Cas9 technology for precision medicine initiatives. Highlighting the potential of interdisciplinary collaborations, elucidating the impact of big data analytics on decision-making processes, this fascinating book will appeal to students and researchers in the pharmaceutical and biotechnological sciences, as well as professionals in this field.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537477873905,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040409299.jpg?v=1786384505"},{"product_id":"sterility-sterilisation-and-sterility-assurance-for-pharmaceuticals-technology-validation-and-current-regulations-woodhead-publishing-series-in-biomedicine-2nd-edition","title":"Sterility, Sterilisation and Sterility Assurance for Pharmaceuticals: Technology, Validation and Current Regulations (Woodhead Publishing Series in Biomedicine), 2nd Edition","description":"\u003cp\u003eby Tim Sandle PhD Sterility, Sterilisation and Sterility Assurance for Pharmaceuticals: Technology, Validation and Current Regulations, Second Edition is an in-depth guide to the world of pharmaceutical sterilization. This new edition has been updated to reflect the latest standards and regulations, ensuring alignment with current practices. It explores emerging methods and techniques, complemented by new case studies that provide practical examples. Readers will gain comprehensive knowledge about sterilization's critical role in healthcare and pharmaceutical manufacturing, highlighting the importance of controlling microbial challenges to ensure product safety and patient well-being.The book discusses sterility, sterilization methods such as gamma radiation, e-beam, dry heat, steam, gas, vapor, filtration, and new techniques like X-ray sterilization, liquid-phase sterilization, ultraviolet light, supercritical gases, and sterilization assurance governance. It covers biopharmaceutical manufacturing processes, including aseptic filling, container and packaging design, and cleanroom environments. This edition is essential for professionals in pharmaceuticals, healthcare, and medical device manufacturing, providing the knowledge needed to comply with current standards and regulations. - Includes nine new chapters with many new case studies - Offers coverage on the most current standards and regulations - Provides full coverage of novel sterilization methods\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537478529265,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443364372.jpg?v=1786384507"},{"product_id":"therapies-for-treatment-resistant-depression-neuropharmacology-and-neurostimulation","title":"Therapies for Treatment-Resistant Depression: Neuropharmacology and Neurostimulation","description":"\u003cp\u003eby James Murrough MD, PhD (ed.), Dennis Charney MD (ed.) Therapies for Treatment-Resistant Depression: Neuropharmacology and Neurostimulation provides readers with an authoritative, comprehensive and targeted treatment guide. The first section reviews the essential knowledge and methods of clinical neuroscience and neuropsychopharmacological techniques as they apply to novel treatment discovery for depression. This is followed by detailed chapters on ketamine, esketamine, other glutamate modulators in development, GABA modulators, neuropeptides, anti-inflammatory agents, and other classes of novel therapeutics under study for TRD and related mood disorders.The last section consists of a set of chapters of special interest that includes current and future research directions, development of psilocybin-based interventions and other psychedelic compounds currently under study for TRD and advances in biomarker-guided and personalized treatment. Edited by world renowned experts in the field, this book is the ultimate resource for researchers and clinicians. - Defines treatment-resistant depression, including epidemiology - Outlines neuroimaging and brain-based biomarkers in treatment-resistant depression using patient data - Reviews safety and monitoring protocols of ketamine in clinical care\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537479020785,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443160066.jpg?v=1786384508"},{"product_id":"secondary-metabolites-and-drug-discovery","title":"Secondary Metabolites and Drug Discovery","description":"\u003cp\u003eby Umar Ali Dar (ed.), Mohd. Shahnawaz (ed.), Neha Singh (ed.) This book explores the promising potential of plant and microbe-derived compounds in drug discovery, offering insights into safer alternatives to synthetic drugs and highlighting the vital role of natural products in treating diseases with fewer side effects. Plants and microbes are a promising source for natural products with the potential to play a major role in drug discovery. Due to advances in the fields of science, technology, engineering, and medicine, the commercial pharmaceutical industry is growing across the globe. Currently, allopathy uses synthetic pharmaceutical drugs for the treatment of diseases, but this practice also exposes patients to significant side effects. Since ancient times, other systems of medicine have been developed that utilize plant-based extracts and molecules to treat various diseases with fewer side effects. While changes in lifestyle, including diet, have had a significant impact on the increased risks of various diseases, there is substantial scientific evidence, both epidemiological and experimental, that vegetables and fruits are key features of diets associated with lower risks of diseases such as cancers and infections. These efforts to identify and create medications from plants are leading to increased manufacturing for larger clinical trials. The continuing scientific research of medicinal plants will undoubtedly provide a wealth of novel, structurally varied, bioactive chemicals. This edited volume provides an overview of various medical systems, with a special focus on microbial and plant-based drug molecules for treating communicable and non-communicable diseases, making it an invaluable resource for researchers, scientists, and practitioners interested in the potential of plant- and microbe-derived secondary metabolites in the ongoing search for innovative, effective, and safer medicines. Readers will find this book: Provides an overview of different types of sources and drug molecules used in allopathic, homeopathic, ayurvedic, Chinese, and Unani systems of medicine; Highlights past and current methods of alternative, complementary, folklore, and integrative medicines; Discusses the benefits and side effects of the drug molecules used in different systems of medicine at the global level; Explores microbial and plant-based drug molecules for treating various communicable and non-communicable diseases. Audience Researchers, academics, industry, and governmental experts working in the fields of natural science, natural products, synthetic chemistry, pharmacology, and medicinal chemistry.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537479151857,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781394204571.jpg?v=1786384509"},{"product_id":"autoimmune-disorders-and-secondary-plant-metabolites-part-1","title":"Autoimmune Disorders and Secondary Plant Metabolites (Part 1)","description":"\u003cp\u003eby M. S. Ashawat, Aditi Kaushik (ed.), Akash Jain (ed.), Jasmine Chaudhary (ed.), Manish Kaushik (ed.) Autoimmune Disorders and Secondary Plant Metabolites provides a crisp overview of immune system dysfunction, then examines the therapeutic potential of medicinal plants in managing major autoimmune and immune-related disorders such as Type 1 Diabetes, Multiple Sclerosis, Psoriasis, Systemic Lupus, Vitiligo, and Hashimoto’s Thyroiditis. Each chapter identifies disease-specific phytochemicals, explains mechanisms of action, and highlights emerging plant-based pharmacotherapy strategies, while linking traditional pharmacology with modern molecular and diagnostic advances. Key Features: - Provides disease-wise phytochemical insights. - Explains immunomodulatory mechanisms using plant bioactive compounds. - Bridges traditional and molecular pharmacology concepts. - Presents evidence through simplified tables and visuals for comparison.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537479676145,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9798898812348-1.jpg?v=1786384510"},{"product_id":"autoimmune-disorders-and-secondary-plant-metabolites-part-2","title":"Autoimmune Disorders and Secondary Plant Metabolites (Part 2)","description":"\u003cp\u003eby M. Ashawat, Aditi Kaushik (ed.), Akash Jain (ed.), Jasmine Jain (ed.), Manish Kaushik (ed.) Autoimmune Disorders and Secondary Plant Metabolites provides a crisp overview of immune system dysfunction, then examines the therapeutic potential of medicinal plants in managing major autoimmune and immune-related disorders such as Type 1 Diabetes, Multiple Sclerosis, Psoriasis, Systemic Lupus, Vitiligo, and Hashimoto’s Thyroiditis. Each chapter identifies disease-specific phytochemicals, explains mechanisms of action, and highlights emerging plant-based pharmacotherapy strategies, while linking traditional pharmacology with modern molecular and diagnostic advances. Key Features: - Provides disease-wise phytochemical insights. - Explains immunomodulatory mechanisms using plant bioactive compounds. - Bridges traditional and molecular pharmacology concepts. - Presents evidence through simplified tables and visuals for comparison.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537479774449,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9798898812799-1.jpg?v=1786384511"},{"product_id":"drug-repurposing-for-antivirals","title":"Drug Repurposing for Antivirals","description":"\u003cp\u003eby Naresh  Kumar Rangra, Amandeep Singh (ed.), Rohit Bhatia (ed.) Drug Repurposing for Antivirals is a timely volume bridging pharmacology, virology, and computational science to present a cohesive understanding of the scientific and translational potential of drug repurposing in antiviral therapy with innovative strategies of finding new antiviral applications for existing drugs, an approach that shortens development timelines, reduces costs, and accelerates clinical deployment The book covers core concepts, from historical successes to modern applications in combating viral diseases. It explores computational screening, molecular docking, and AI-driven tools for identifying candidate molecules; experimental validation methods; and real-world case studies involving influenza, SARS-CoV-2, HIV, and hepatitis viruses. Special focus is given to host-targeted antivirals, broad-spectrum agents, and strategies to counter viral resistance. Regulatory aspects, challenges, and future directions for integrating repurposed antivirals into clinical practice are also discussed. Key Features: -Integrates theory, methodology, and real-world case studies. -Covers both computational and experimental approaches. -Highlights implications for pandemic preparedness and rapid-response drug discovery. -Includes contributions from leading experts in virology, medicinal chemistry, and pharmacology.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537480298737,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9798898811150-1.jpg?v=1786384512"},{"product_id":"herb-drug-interactions-a-medicinal-approach","title":"Herb-Drug Interactions: A Medicinal Approach","description":"\u003cp\u003eby Pratichi Singh With the global rise in use of herbal medicine alongside conventional drugs, understanding the interactions between them has become critical to ensuring therapeutic effectiveness and patient safety. Herb-Drug Interactions: A Medicinal Approach integrates traditional knowledge, modern pharmacology, and computational tools to provide a holistic perspective on herb-drug interactions. The book covers the historical evolution of herbal medicine, chemistry and mechanisms of herb-drug interactions, pharmacodynamics in metabolic diseases, and clinical implications. It also explores transport mechanisms, healthcare applications, and advanced computational approaches, including databases and bioinformatics tools. Special attention is given to vulnerable populations such as children, the elderly, and pregnant women, offering practical clinical insights. By combining mechanistic understanding with real-world applications, the book serves as both a reference and a guide for advancing safe, evidence-based integrative healthcare. Key Features: - Integrates traditional herbal knowledge with modern pharmacology and computational approaches. - Explains mechanisms, pharmacodynamics, and clinical implications of herb-drug interactions. - Highlights therapeutic potential, drug-herb synergy, and safety considerations. - Focuses on vulnerable populations: paediatrics, geriatrics, and pregnancy. - Provides practical guidance for evidence-based integrative healthcare.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537480397041,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9798898811549-1.jpg?v=1786384513"},{"product_id":"advanced-liposome-technologies-preparation-mechanisms-and-applications","title":"Advanced Liposome Technologies: Preparation, Mechanisms, and Applications","description":"\u003cp\u003eby Chandra Has Delivered by Amazon Amazon Delivered by Amazon Sold by Epitome Books Epitome Books Sold by Epitome Books Payment Secure transaction Your transaction is secure We work hard to protect your security and privacy. Our payment security system encrypts your information during transmission. We don’t share your credit card details with third-party sellers, and we don’t sell your information to others.     Learn more\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537481052401,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9798898813345.jpg?v=1786384514"},{"product_id":"special-issues-in-pharmacovigilance-in-resource-limited-countries","title":"Special Issues in Pharmacovigilance in Resource-Limited Countries","description":"\u003cp\u003eby Syed Rizwanuddin Ahmad (ed.) Examining the state of pharmacovigilance systems in resource-limited countries, this book addresses the critical role that pharmacovigilance systems play, as drugs and vaccines become increasingly accessible in these settings. Issues unique to these countries are explored, including medical product safety and quality problems, the nature of support needed to build pharmacovigilance system capacity to effective level, global and regional strategies and efforts to develop institutional and professional capacity; the challenges being faced and how these are being tackled. This book is a must-read resource for anyone involved in the provision of safe, and quality medical products; and its rational use in resource-limited settings, including staff of pharmacovigilance centers, regulatory authorities, academia, contract research organizations, the pharmaceutical industry, donor agencies and technical assistance providers. This book is unique in its focus on pharmacovigilance in resource-limited countries (RLCs). Many RLCs face serious challenges in maintaining health care systems, ensuring access to essential medicines and promoting drug safety. The editor has built an exceptional and well-balanced pharmacovigilance compendium. The individual chapters by experts provide a valuable resource of national and regional pharmacovigilance experiences. A very good read not only for pharmacovigilance professionals in RLCs, but also for donors and other international organisations. Hubert G Leufkens, PhD, FISPE, Professor of Pharmaceutical Policy and Regulatory Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Former Head of the Dutch regulatory agency (MEB), The Netherlands I foresee this collection will become a very useful reference for everyone working or supporting the development of pharmacovigilance in countries with limited resources. We have utilized the services of Dr. Ahmad on several occasions. His passion and focus on important issues resonates throughout the book. Adel Al-Harf, PhD, Vice President of the Drug Sector, Saudi Food and Drug Authority (SFDA), Kingdom of Saudi Arabia\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537481707761,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9789819661541.jpg?v=1786384516"},{"product_id":"deep-learning-in-drug-design-methods-and-applications","title":"Deep Learning in Drug Design: Methods and Applications","description":"\u003cp\u003eby Qifeng Bai PhD (ed.), Tingyang Xu PhD (ed.), Junzhou Huang PhD (ed.) Deep Learning in Drug Design: Methods and Applications summarizes the most recent methods, and technological advances of deep learning for drug design, which mainly consists of molecular representations, the architectures of deep learning, geometric deep learning, large models, etc., as well as deep learning applications in various aspects of drug design. This book offers a comprehensive academic overview of deep learning in drug design. It begins with molecular representations, CNNs, GNNs, Transformers, generative models, explainable AI, large models, etc. Next, it covers deep learning applications like protein structure prediction, molecular interactions, ADMET prediction, antibody design, and so on. Finally, a separate chapter is dedicated to the introduction of the ethics and regulation of artificial intelligence in drug design. This book is ideal for readers aiming to learn and implement deep learning methods and applications in drug design and related fields. Deep Learning in Drug Design: Methods and Applications is particularly helpful to undergraduate, graduate, and doctoral students in need of a practical guide to the principles of the discipline. Established researchers in the area will benefit from the detailed case studies and algorithms presented. Introduces the basic theories, current methods, and principles of deep learning for drug design Presents the major application fields of drug design based on deep learning including protein folding, retrosynthesis prediction, molecular generation, molecular docking, and ADMET prediction, among others Details explainable artificial intelligence for drug design models\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537482199281,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443329081.jpg?v=1786384517"},{"product_id":"biopharmaceutical-ecosystems-a-comparative-study-of-us-and-european-systems","title":"Biopharmaceutical Ecosystems: A Comparative Study of U.S. and European Systems","description":"\u003cp\u003eby David R. Williams The ecosystem perspective on organizations and economic settings is relatively new. It expands on work that looks at bio-clusters, concentrating on the relationship between human and financial capital. The perspective takes an expansive view of biopharmaceuticals in relation to stakeholders and the social, political, and economic landscape, including other life science companies, academia, non-profits, government entities, and health systems. The biotechnology and pharmaceutical industries have been merging for some time, with biotechnology often portrayed as a disruptive innovation to the pharmaceutical industry. A fuller description of this activity put into the greater context of the ecosystem perspective is warranted.Biopharmaceutical Ecosystems: A Comparative Study of U.S. and European Systems puts forward a picture of biopharmaceutical ecosystems in the USA and Europe. It examines and expands current thinking on the development of the ecosystem perspective on biopharmaceuticals. The title considers multiple locations, with countries in the top 15 of biopharmaceutical exporters selected. It pays particular attention to shifts in the political and economic landscape, and how such changes affect ecosystems. The underlying aim of biopharmaceutical ecosystems is to further the development of new drugs, reduce time to market, and lower costs. In explaining ecosystems, the book applies a quadruple helix model - academia; consumer\/society; government; and industry - to each region and country in light of this triple aim. - Applies the ecosystem perspective to the biopharmaceutical industry, looking at the relationship between human and financial capital - Provides a one-stop solution for stakeholders interested in comparing US and European biopharmaceutical ecosystems - Examines ecosystems within countries in the top 15 of biopharmaceutical exporters worldwide - Considers how each ecosystem furthers drug development, reduces time to market, and reduces costs - Uses a rigorous methodology to understand how shifting political and economic factors affect biopharmaceutical ecosystems and their productivity in the US and Europe\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537482297585,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780128206225.jpg?v=1786384519"},{"product_id":"nanomedicine-advancements-and-intersectional-perspectives-for-womens-health","title":"Nanomedicine Advancements and Intersectional Perspectives for Women’s Health","description":"\u003cp\u003eby Pankaj Sharma PhD (ed.), Vinay Jain PhD (ed.) Nanomedicine Advancements and Intersectional Perspectives for Women's Health provides detailed insights and innovative treatments that specifically address health issues that women face. It provides valuable information and practical solutions based on scientific evidence providing comprehensive information about nanomedicine advancements specifically targeted towards improving health outcomes. It offers clear explanations of complex medical concepts in nanomedicine in a reader-friendly manner to help bridge the knowledge gap on this topic. By providing clear explanations, real-life examples, and practical insights, it empowers readers with valuable information that can help healthcare professionals make informed decisions working in relevant fields as well as researchers new to the field. - Provides the latest expert insights and research findings for both healthcare professionals and researchers - Includes practical tips and strategies utilizing specific nanotechnology advancements for better health outcomes for women - Explores intersectionality by showcasing people that have multiple dimensions to their identity (e.g., race, gender, sexuality)\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537482789105,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443330575.jpg?v=1786384520"},{"product_id":"curcumin-bioavailability-and-sustainability-as-therapeutic-agent-strategies-for-sustained-release-curcumin","title":"Curcumin Bioavailability and Sustainability as Therapeutic Agent: Strategies for Sustained Release Curcumin","description":"\u003cp\u003eby Mahmood Ahmed PhD, Syed Salman Shafqat PhD Curcumin Bioavailability and Sustainability as Therapeutic Agent: Strategies for Sustained Release Curcumin is a comprehensive reference on techniques to enhance the bioavailability of curcumin, while also covering sustainability aspects across its production cycle. This book focuses on the information needs of pharmaceutical scientists aiming at developing drug delivery systems and formulations that can maximize the therapeutic impact of curcumin drugs. After an introduction to curcumin therapeutic properties, the authors delve into the bioavailability challenges confronted by curcumin, discussing influencing factors, pharmacokinetic pathways, and formulations to augment its bioaccessibility. Chapter 3 explores innovative formulation paradigms, encompassing nanoparticle-based delivery systems and lipidic matrices, tailored to overcome solubility limitations and increase absorptive efficacy. Chapter 4 covers delivery systems, encompassing prodrug strategies, encapsulation modalities, and nanocarrier technologies. Chapter 5 investigates sustainable sourcing and production, raising awareness to ethical cultivation practices, eco-friendly extraction methodologies, and proficient waste management techniques within curcumin production processes. In Chapter 6 discusses balancing bioavailability augmentation with sustainability principles including case studies. Chapter 7 navigates the domain of pharmacokinetic studies and clinical trials, providing an overview of bioaccessibility and bioavailable formulations. Chapter 8 explores safety profiles, regulatory requirements, and quality benchmarks, encompassing product labeling and claims concerning curcumin's bioavailability and sustainability. Chapter 9 casts a future view contemplating nascent technologies for bioavailability and sustainability optimization. The final chapter concludes the book with the author's observations on its central themes. Curcumin Bioavailability and Sustainability as Therapeutic Agent: Strategies for Sustained Release Curcumin provides practical strategies to be explored by pharmaceutical scientists in increasing bioavailability of curcumin formulations. Research physicians and nutritionists may also benefit from the evidence-based information on curcumin's therapeutic activities provided across the book. - Provides in-depth exploration of bioavailability and sustainability of curcumin as a medicinal agent - Focuses on scientific research and evidence-based practice, including the latest studies and discoveries on the stability and sustainability of curcumin - Includes practical applications and optimization strategies for the effective use of curcumin as a medicinal agent\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537483313393,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443291975.jpg?v=1786384521"},{"product_id":"strategies-to-modify-the-drug-release-from-pharmaceutical-systems-woodhead-publishing-series-in-biomedicine-2nd-edition","title":"Strategies to Modify the Drug Release from Pharmaceutical Systems (Woodhead Publishing Series in Biomedicine), 2nd Edition","description":"\u003cp\u003eby Marcos Luciano Bruschi PhD Strategies to Modify the Drug Release from Pharmaceutical Systems, Second Edition serves as a vital reference on contemporary models aimed at achieving the precise therapeutic dosage and timing of drug release. The book provides updated strategies, mathematical models, routes of administration, and technologies, all presented succinctly and objectively. This six-chapter guide covers general concepts of drug release modification and classification of therapeutic systems, including passive versus active targeting. It delves into mechanisms to control drug release, discussing materials and technologies, and introduces mathematical and physicochemical models of drug release.Furthermore, it reviews drug delivery systems like 3D printing, nose-to-brain delivery, environmentally responsive systems, and new lipid systems, making it indispensable for pharmaceutical scientists, graduate students, materials scientists, and chemists. - Includes up to date physicochemical principles and mathematical models - Covers new drug delivery systems such as 3D printed systems - Presents the advances in drug delivery from the past decade\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537483575537,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443333583.jpg?v=1786384522"},{"product_id":"handbook-of-melatonin-based-therapy-and-its-applications","title":"Handbook of Melatonin-Based Therapy and its Applications","description":"\u003cp\u003eby Alejandro Romero Martínez PhD (ed.), Eva Ramos Alonso PhD (ed.), Francisco López-Muñoz PhD (ed.) Handbook of Melatonin-Based Therapy and its Applications provides pharmaceutical researchers and health professionals with a comprehensive reference on the applications of melatonin in the therapeutic setting. Succinct, meticulously organized, and expertly written, this book addresses all essential aspects. It starts with an overview of safe use of melatonin, translational aspects, and its prospection. The next section of the book covers a variety of clinical applications, including dosage, pharmacokinetics and pharmacodynamic profiles, toxicity, and principles of action. The chapters in this section cover applications to both adults and pediatric patients suffering from conditions like skin cancers, GI issues, psychiatric, hepatic and ocular conditions.This is a comprehensive resource for pharmaceutical scientists and health professionals involved in developing therapies and applying them to patients. Researchers in the fields of medicine, biology, neuroscience, and pharmacology conducting studies related to melatonin-based will benefit from insights into the latest research findings, clinical trials, and therapeutic approaches. - Covers the most significant clinical aspects where melatonin has been shown to be effective - Summarizes research progress and therapeutic applications of melatonin - Provides a platform for researchers from diverse fields to collaborate and advance our understanding of the field\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537484099825,"sku":null,"price":49.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443302411.jpg?v=1786384523"},{"product_id":"next-generation-probiotics-current-developments-in-agricultural-biotechnology-and-food-security","title":"Next Generation Probiotics (Current Developments in Agricultural Biotechnology and Food Security)","description":"\u003cp\u003eby Shakira Ghazanfar (ed.), Charles Oluwaseun Adetunji (ed.), Alessandro Di Cerbo (ed.), Ghulam Muhammad Ali (ed.), Wajya Ajmal (ed.), Muhammad Naeem Riaz (ed.) Next Generation Probiotics: From Novel Drugs to Future Therapeutics provides a comprehensive and cutting-edge exploration of probiotics as powerful therapeutic agents. With the rapid advancements in the field, this book offers a deep dive into how probiotics are evolving beyond traditional uses, addressing complex health conditions and diseases in modern medicine. By combining the latest scientific research with practical applications, this book equips researchers, clinicians, and healthcare professionals with the knowledge needed to incorporate probiotics into clinical practice and future therapeutic strategies. The book covers a wide range of essential topics, including: Probiotic mechanisms and the chemical characterization of bioactive compounds derived from probiotics The emerging role of probiotics in gut-brain interactions and psychobiotics for mental health Probiotic-based drug development and their applications in personalized medicine Probiotics in the prevention and treatment of gastrointestinal disorders, metabolic diseases, and cancer The integration of next-generation sequencing and machine learning in optimizing probiotic therapies Probiotics in functional foods and their potential to alleviate lactose intolerance Applications in animal health, focusing on terrestrial and aquatic animals This book stands out by offering an exhaustive examination of probiotics in therapeutic applications, providing real-world examples and insights into how these microorganisms are reshaping modern medicine. Next Generation Probiotics is a must-read for researchers, clinicians, and healthcare professionals interested in the future of probiotics as a therapeutic tool for a wide range of health challenges.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537484689649,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781032516387-1.jpg?v=1786384525"},{"product_id":"bioavailability-of-nutraceuticals-and-bioactive-compounds-functional-foods-and-nutraceuticals","title":"Bioavailability of Nutraceuticals and Bioactive Compounds (Functional Foods and Nutraceuticals)","description":"\u003cp\u003eby Xiaohong Sun (ed.), Chibuike Udenigwe (ed.) Nutraceuticals and bioactive compounds are gaining increased attention from scientists, industry professionals, and consumers for their significant biological functions and health benefits beyond basic nutrition. Oral bioavailability is a key determinant of their physiological effects, making it essential to optimize their benefits and translate scientific discoveries into practical applications. This comprehensive book provides an in-depth exploration of the bioavailability of nutraceuticals and bioactive compounds. It covers the fundamental principles, assessment methods, influencing factors, and strategies to enhance bioavailability. The book places particular emphasis on the individual forms of nutraceuticals and bioactive compounds. By bridging the gap between fundamental science and practical applications, it highlights cutting-edge research and emerging technologies in nutraceuticals and functional foods. What sets this book apart is its targeted focus on oral bioavailability, integrating perspectives from food science, biochemistry, and pharmacokinetics. It offers actionable insights and strategies to support the development of more effective nutraceuticals and dietary supplements.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537485213937,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040416372.jpg?v=1786384526"},{"product_id":"cutting-edge-strategies-in-drug-delivery-and-immunotherapy-for-autoimmune-disorders","title":"Cutting-Edge Strategies in Drug Delivery and Immunotherapy for Autoimmune Disorders","description":"\u003cp\u003eby Young-Ok Son (ed.), Mrinmoy Ghosh (ed.) Autoimmune diseases represent a significant and complex global health burden, particularly among women, yet their underlying causes remain only partially understood. Affecting nearly every organ system, these conditions are driven by intricate interactions between genetic susceptibility, epigenetic modifications, and environmental triggers such as viral infections and toxins. With over 80 distinct autoimmune disorders identified—ranging from systemic to organ-specific—diagnosis and treatment continue to pose substantial clinical challenges. Despite progress in identifying autoantibodies and disease mechanisms, current therapies fall short of inducing long-term immune tolerance or preventing disease progression. This book offers a comprehensive exploration of the latest research into the molecular, genetic, and cellular underpinnings of autoimmune disease pathogenesis. It presents emerging therapeutic approaches grounded in advanced computational modeling, systems biology, and bioinformatics, as well as the design of novel bioactive compounds. A particular focus is placed on next-generation, nanoparticle-based drug delivery systems that promise to transform the treatment landscape by enhancing targeting specificity and minimizing systemic side effects. With in-depth coverage of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), and Multiple Sclerosis (MS), this volume serves as a critical resource for specialists, researchers, and clinicians seeking to deepen their understanding of autoimmune disease mechanisms and therapeutic innovation. Through interdisciplinary insights and a forward-looking perspective, the book aims to accelerate the development of precision treatments that can significantly improve patient outcomes and quality of life.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537485738225,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9789819505203.jpg?v=1786384528"},{"product_id":"grapes-and-health-2nd-edition","title":"Grapes and Health, 2nd Edition","description":"\u003cp\u003eby John M. Pezzuto (ed.) Since the publication of the first edition of Grapes and Health, much research funding has been invested in the further examination of the health-promoting benefits of grapes, exploring areas such as brain health, eye and heart health, as well as more novel areas such as skin health and microbiomics. The wide scope and diversity of the research on grapes and their benefits for human health suggests the necessity of a comprehensive and up-to-date overview of the subject. Updating and expanding on its first edition, Grapes and Health (2nd ed.) accounts for the increased use of human trials in researching the effects of grapes on health, thereby demonstrating even more directly the diverse benefits that this fruit can offer the average person by inclusion into their diet. This volume recognizes the power of eating real, simple foods for lasting health-promoting and disease-preventing effects. Experts across the fields of nutrition, microbiomics, pharmacology and more offer their insights into the various mechanisms by which grapes can bolster health and nutrition, improving quality of life and longevity. In Grapes and Health (2nd ed.), food science researchers, grape growers and health professionals alike will find a guide to the varied and complex ways in which this one food item can impact the body. Consumers, meanwhile, will discover a new perspective on this commonplace but often overlooked staple of their diet.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537485836529,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9783031969133.jpg?v=1786384529"},{"product_id":"side-effects-of-drugs-annual","title":"Side Effects of Drugs Annual","description":"\u003cp\u003eby Sidhartha D. Ray Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 47 first published in 1977, presents clinicians and medical investigators with a critical survey of new data and trends in adverse drug reactions and interactions. Topics covered include ADRs, ADEs and SEDs: A Bird's Eye View, Lithium, Drugs of abuse, Side effects of drugs used in the treatment of Alzheimer's disease, Sedatives and hypnotics, Antipsychotic agents, Anti-epileptic Medications, Side effects of opioid analgesics and narcotic antagonists, Anti-inflammatory and antipyretic analgesics and drugs used in gout, Side effects of local anesthetics and therapeutic gases, and more.Other sections covered include Antihistamines (H1 receptor antagonists), Drugs that act on the respiratory tract, Positive inotropic drugs and drugs used in dysrhythmias, Beta adrenergic antagonists and antianginal drugs, Drugs acting on the cerebral and peripheral circulations, Antihypertensive drugs, and much much more. - Provides a critical yearly survey of the new data and trends regarding the side effects of drugs - Authored and reviewed by worldwide pioneers in the clinical and practice sciences - Presents an essential clinical guide on the side effects of drugs for practitioners and healthcare professionals alike\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537488752881,"sku":null,"price":64.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443344862.jpg?v=1786384536"},{"product_id":"natural-occurrence-and-biological-activities-of-quinoline-derivatives-new-directions-in-organic-biological-chemistry","title":"Natural Occurrence and Biological Activities of Quinoline Derivatives (New Directions in Organic \u0026 Biological Chemistry)","description":"\u003cp\u003eby Shahriar Khadem This latest volume in the New Directions in Organic \u0026amp; Biological Chemistry series provides a comprehensive overview of quinoline derivatives, focusing on their chemical structure, biological activities, and therapeutic benefits. It delves into the natural sources of these derivatives, covering their isolation, characterization, and potential therapeutic applications, particularly in areas such as anti-cancer, anti-inflammatory, antimicrobial, and antimalarial activity. With its emphasis on providing valuable reference material, this book is an indispensable resource for researchers, educators, and professionals in the fields of chemistry, biology, pharmacology, and drug discovery. Key Features Delves into the study of chemistry related to natural products and their medicinal applications, focusing on the origins of compounds, their chemical characteristics, effects on biology, and potential for treatment. Provides actionable insights into how chemical compounds are applied in the real world, targeting ailments such as cancer, inflammation, infections, and malaria. Provides an overview of the research in the field of natural and medicinal chemistry, appealing to those working in pharmaceutical companies and engaged in drug discovery efforts. Acts as an essential educational tool for a wide audience, including students, researchers, educators, and practitioners in the field.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537488883953,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040767672.jpg?v=1786384538"},{"product_id":"medicinal-compounds-in-modern-healthcare-from-tradition-to-innovation","title":"Medicinal Compounds in Modern Healthcare: From Tradition to Innovation","description":"\u003cp\u003eby Vibhav Gautam (ed.), Hemant K. Gautam (ed.), Rajiv Pathak (ed.), Lalit Kumar (ed.) This book reviews the evolution, development, and application of medicinal compounds, beginning with their historical context and advancing to modern innovations. The book describes the therapeutic potential of bioactive compounds from microorganisms, the role of antioxidants and anti-inflammatory agents in managing chronic diseases, and the use of small molecules in pain management and mental healthcare. It further explores immunomodulatory compounds, epigenetic modifiers, and the latest advancements in drug development, including integrative medicine approaches and the applications of nanotechnology in traditional medicine. Additionally, the book addresses the use of immunomodulatory agents like methotrexate and paclitaxel in cancer treatment, regulatory considerations for ensuring safety and efficacy in medicinal compounds, and the growing field of nutraceuticals. Towards the end, the book covers the extraction, profiling, and ADMET evaluation of medicinal compounds, intellectual property challenges, and the significance of traditional medicine in modern healthcare. Key Features: Reviews the development of medicinal compounds from historical remedies to modern innovations Presents the therapeutic potential of bioactive compounds from microorganisms and the crucial roles of antioxidants and anti-inflammatory agents in disease management Describes the innovations in drug delivery systems, epigenetic modifiers, and immunomodulatory agents Provides guidance on regulatory considerations and intellectual property in medicinal compound development Examines the role of nanotechnology and the integration of traditional and modern therapies This book is intended for researchers of ethnopharmacology, pharmaceutical sciences, and medicinal chemistry.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537490587889,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040541265.jpg?v=1786384541"},{"product_id":"medicinal-and-aromatic-plants-of-oman-phytochemistry-and-ethno-pharmacological-aspects-volume-1","title":"Medicinal and Aromatic Plants of Oman: Phytochemistry and Ethno-Pharmacological Aspects, Volume 1","description":"\u003cp\u003eby Ahmed Al-Harrasi, Ahmed Al-Rawahi, Saif Amur Al Hatmi, Saurabh Bhatia Medicinal plants have received an impetus recently due to the revival of attention to natural products in the form of herbal medicines, demanding convincing knowledge on their phytochemistry, status, cultivation, and utilization. Medicinal plants in the Sultanate of Oman have tremendous potential in terms of ethnomedicinal and food applications. However, these treasures of Oman have not been fully explored until recently. Several medicinal plants indigenous to Oman have been used for several centuries in the form of traditional medicine for the prevention and treatment of diseases. The first volume of this book covers information about sustainable use of selected medicinal plants, their phytochemistry, and efforts made to conserve them to ensure continued supply. This volume reveals systematic information about 104 to 151 promising medicinal plants in Oman with botanical names, common names, synonyms, local names, family, habitat and distribution, chemical constituents, pharmacological activity, uses (common uses, traditional uses and therapeutic uses), toxicity and clinical data, patents, and their marketed products or industrial application. Each of the 151 plants has a high-resolution color photograph (where available), plant description, and location. The chapters are written by well-experienced authors in the field. A uniform chapter structure throughout this book has been designed to maintain consistency. This book is especially valuable to academicians, phytochemists, pharmacologists, herbalists, agriculturists, biotechnologists, natural product researchers and industrialists involved in the production of herbal drugs. Salient features of this book are as follows: Ιt provides common uses, traditional uses, and therapeutic uses of 132 medicinal plants It covers the detailed phytochemistry of each medicinal plant It offers systematic information about the geographical distribution of these plants Updated information about the pharmacology, mechanisms of action, and toxicity of these plants is covered in detail Overall, this book provides an overview of botanical description, geographical distribution, chemical composition and uses of the medicinal plants native to the Sultanate of Oman. Many of the plants listed in this book—particularly in Volume One—are endemic, near‑endemic, or regionally endemic medicinal and aromatic species of Oman, which remain largely unexplored and are supported by limited scientific literature. Due to this scarcity of information, the authors have included relevant data from closely related species within the same genus. This approach enables readers to better understand the chemistry, taxonomy, and potential uses of the respective species in the context of their taxonomic relatives.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537491144945,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040394632-1.jpg?v=1786384542"},{"product_id":"cutaneous-adverse-drug-reactions-a-case-based-approach-for-deeply-pigmented-skin-series-in-dermatological-treatment","title":"Cutaneous Adverse Drug Reactions: A Case Based Approach for Deeply Pigmented Skin (Series in Dermatological Treatment)","description":"\u003cp\u003eby Swetalina Pradhan (ed.), Piyush Kumar (ed.) This concise practical guide is designed to facilitate the clinical decision-making process in the management of Cutaneous Adverse Drug Reactions by reviewing a number of cases and defining the various diagnostic and management decisions open to clinicians. Well-illustrated and diverse in scope, the text will allow readers to obtain relevant information for both standard and unusual cases in a rapid, easy-to-digest format.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537491243249,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040424797_9ab95f72-ee57-4ba7-a4f0-7fd7101471c7.jpg?v=1786384543"},{"product_id":"ai-and-precision-medicine-in-infectious-disease-management-ai-in-clinical-practice","title":"AI and Precision Medicine in Infectious Disease Management (AI in Clinical Practice)","description":"\u003cp\u003eby Jen-Tsung Chen (ed.) This book presents technical advancements of artificial intelligence (AI)–based technologies and computational biology approaches, highlighting their applications in developing smart healthcare and precision medicine for managing infectious diseases. It discusses cutting-edge AI tools, particularly machine and deep learning models, and generative AI to assist in disease prediction and prevention, disease surveillance and diagnosis, drug discovery, drug design and development, healthcare, personalized medicine, pharmacology, and vaccine development. The contents fit the goal of establishing \"Good Health and Well-Being,\" which is one of the \"Sustainable Development Goals (SDGs) 2030.\" Key Features: • Includes AI\/omics approaches in precision medicine and smart healthcare • Summarizes AI-driven drug and vaccine developments and AI tools for infectious disease prevention for clinicians, researchers, and policymakers • Proposes AI-based strategies for disease prediction, surveillance, and diagnosis\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537492226289,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781041016212.jpg?v=1786384545"},{"product_id":"nanotechnology-and-drug-delivery-innovations-in-lung-cancer-treatment","title":"Nanotechnology and Drug Delivery Innovations in Lung Cancer Treatment","description":"\u003cp\u003eby PARTEEK PRASHER (ed.), MOUSMEE SHARMA (ed.), Indu Pal Kaur (ed.), Ronan Macloughlin (ed.), Raimar Loebenberg (ed.), Neal Davies (ed.), Kamal Dua (ed.) This book examines the role of nanotechnology in transforming the diagnosis, treatment, and management of lung cancer. The initial chapters introduce lung cancer through its epidemiology, pathophysiology, and immunological mechanisms. The subsequent chapters emphasize the role of novel nanoparticles in early detection and imaging of lung cancer. The book then explores the potential of different nanomaterials, such as metal and metal oxide nanoparticles, nano micelles, carbon nanotubes, liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrimers, nanofibers, and quantum dots, in lung cancer treatment. Each chapter focuses on the unique properties from targeted drug delivery to improved bioavailability and reduced side effects. Exploring theragnostic nanoparticles, the book highlights their dual role in diagnosis and therapy, alongside nano-immunotherapy strategies for improved cancer treatment. The book concludes with a critical review of ongoing clinical trials, offering insights into the future of nanotechnology-based lung cancer therapies and emerging trends in the field. Key Features: Details the epidemiology and pathophysiology of lung cancer, covering disease prevalence, risk factors, and cellular mechanisms Examines the diagnostic capabilities of nanotechnology, emphasizing the use of nanoparticles in early detection and imaging Explores the therapeutic potential of various nanomaterials, such as liposomes, dendrimers, and quantum dots, for enhanced drug delivery and treatment Highlights theranostic nanoparticles, combining diagnostic and therapeutic functions for personalized cancer care Reviews clinical trials and emerging trends, providing insights into the future of nanotechnology-based lung cancer therapies The book is intended for researchers of oncology, nanomedicine, pharmaceutical sciences, and biomedical engineering.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537492357361,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040586587.jpg?v=1786384546"},{"product_id":"biosimilars-and-interchangeable-biologics-strategic-elements-2nd-edition","title":"Biosimilars and Interchangeable Biologics: Strategic Elements, 2nd Edition","description":"\u003cp\u003eby Sarfaraz K. Niazi This new edition explores the strategic planning side of biosimilar drugs and targets the issues surrounding biosimilars that are linked to legal matters. This includes an examination of new regulatory requirements in terms of principal patents and intellectual property, regulatory pathways, and concerns about affordability on a global scale. Biosimilars and Interchangeable Biologics: Strategic Elements,Second edition, examines the science, technology, finance, legality, ethics, and politics of biosimilar drugs. The book presents a global strategy on how to build, take to market, and manage the next generation of biosimilars throughout their life cycle. Updated throughout, the book covers strategic planning elements that include an overall understanding of the history and the current status of the science and art of biosimilars. As the perception of biosimilars has changed over the last several years, the author provides detailed descriptions of the new legal, regulatory, and commercial characteristics that must be considered. He also addresses the utilization of biosimilars and related biological drugs in expanding world markets, and reviews new strategies and tactics to enable users to create a universal dossier. Finally, there is also an examination of newer technologies that will help reduce the capital costs of manufacturing and bringing biosimilars to market. The book is intended for pharmaceutical scientists, engineers in biotechnology, regulatory specialists, analytical chemists, and quality assurance specialists in biopharmaceuticals.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537492979953,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040689899.jpg?v=1786384548"},{"product_id":"pharmaceutical-regulatory-affairs-principles-and-practices","title":"Pharmaceutical Regulatory Affairs: Principles and Practices","description":"\u003cp\u003eby Nimisha Srivastava (ed.), Neeraj Mishra (ed.), Sumel Ashique (ed.), Bharanitharan Rajendran (ed.) This book provides concepts, procedures, guidelines, and regulatory affairs in drug development. Pharmaceutical Regulatory Affairs: Principles and Practices begins with a detailed overview of the drug development life cycle, from initial discovery and preclinical research to clinical trials and market approval, addressing scientific, regulatory, and ethical considerations at each stage. The book covers the evolution of global trade agreements like the General Agreement on Tariff and Trades (GATT) and the World Trade Organization’s (WTO) impact on pharmaceuticals, highlighting issues surrounding pharmaceutical patents and intellectual property rights. It discusses the importance of the Scale-Up and Post-Approval Changes (SUPAC) guidelines in ensuring quality and consistency in drug manufacturing post-approval and examines the World Health Organization's (WHO) guidelines on technology development and transfer. The fundamentals of regulatory affairs are covered, emphasizing the roles and responsibilities of regulatory professionals. The book provides an in-depth look at regulatory frameworks of major agencies worldwide, including the Central Drugs Standard Control Organization (CDSCO) in India, the Food and Drug Administration (FDA) in the US, the European Medicines Agency (EMA) in the EU, the Therapeutic Goods Administration (TGA) in Australia, the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, Health Canada, and regulatory authorities in emerging markets. It also addresses the international regulatory landscape for medical devices and reviews foundational pharmaceutical regulations. Additionally, the text explores regulatory guidelines for clinical testing, including the roles and responsibilities under pharmaceutical legislation, principles of bioethics and biosafety, the digital transformation in clinical trials, and the critical role of pharmacovigilance. The book concludes with an examination of the global regulatory scenario for pharmaceutical excipients, providing a detailed roadmap through the complexities of drug development, regulatory compliance, and global standards. This book is valuable for professionals, researchers, and students of pharmaceutical sciences.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537493700849,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040644492.jpg?v=1786384550"},{"product_id":"recent-advancements-in-tuberculosis-drug-discovery","title":"Recent Advancements in Tuberculosis Drug Discovery","description":"\u003cp\u003eby Vivek P. Chavda (ed.), Mahesh T. Chhabria (ed.), Divya M. Teli (ed.) Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance. The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537494290673,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040812556-1.jpg?v=1786384552"},{"product_id":"medicinal-cannabis-in-womens-health","title":"Medicinal Cannabis in Women’s Health","description":"\u003cp\u003eby Kylie O'Brien, Carolyn Bosak This book explores the scientific evidence for the medical use of cannabis in the treatment of common conditions affecting women. Drawing on their experience and knowledge in research and clinical practice, this book by Dr Kylie O’Brien and Dr Carolyn Bosak has been written to assist healthcare professionals to become more informed about the potential role of medicinal cannabis in women’s healthcare, within the context of an integrative approach to treatment. The book sets out the rationale for why medicinal cannabis may be useful in the treatment of anxiety, depression, chronic pelvic pain, primary dysmenorrhea, endometriosis, menopause symptoms, and osteoarthritis. Early chapters explain the important roles of the endocannabinoid system in the functioning of our mind-body and delves into what medicinal cannabis encompasses, including key components, mechanisms of action and safety aspects. The clinical chapters explore each of the above-mentioned conditions, including known pathophysiology and changes in the endocannabinoid system, and examine the current state of scientific research into medicinal cannabis for their treatment. Clinical chapters also include case studies to illustrate how medicinal cannabis may be used in clinical practice. The final chapter provides guidance on how medicinal cannabis may be integrated into a holistic treatment approach as well as commentary on research issues in this field. Despite the growing interest in the medical use of cannabis by consumers, women in particular, there has been relatively little published in the form of books about the potential use of medicinal cannabis for the treatment of conditions affecting women. This book helps fill that gap. Medicinal Cannabis in Women’s Health: An Evidence-Based Clinician’s Guide will be of great interest to medical practitioners, nurses, pharmacists, and other healthcare practitioners who are prescribing medicinal cannabis, considering prescribing it or simply want to be informed about the evidence base of its use in common conditions facing women.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537494814961,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9783032017369.jpg?v=1786384552"},{"product_id":"ketamine","title":"Ketamine","description":"\u003cp\u003eby Albert Dahan PhD (ed.), David Dadiomov PhD (ed.) Pharmacology of Ketamine: Fundamentals, Applications, Delivery Systems and Clinical Aspects explores the multifaceted properties of ketamine for diverse applications, delving into dosing strategies, routes of administration, and their pharmacological implications. The book begins with an introduction that underscores the need to bridge research and practice. It then delves into the pharmacological intricacies of ketamine, dissecting mechanisms and dosing strategies and exploring the diverse routes of administration and their impact on ketamine's metabolites.The book then explores the PK and PD characteristics of ketamine, followed by a deep dive into clinical applications emphasizing anesthesia, psychiatric therapy, and emerging treatments. The final part of the book covers addiction, toxicity, and future research perspectives. It will serve as a comprehensive reference tailored to the needs of both researchers and clinicians involved in the administration and study of ketamine. - Summarizes current literature and evidence based research of ketamine from a pharmacological and clinical perspective - Provides an interdisciplinary perspective on the use of ketamine in research and clinical settings - Considers the future research directions of ketamine\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537494880497,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443299308.jpg?v=1786384554"},{"product_id":"oral-delivery-of-insulin-2nd-edition","title":"Oral Delivery of Insulin, 2nd Edition","description":"\u003cp\u003eby T.A. Sonia PhD, Chandra P. Sharma PhD Oral delivery of Insulin, Second Edition is a complete reference on non-invasive insulin delivery systems, focusing on the prospect of oral delivery of peptides. The chapters in the revised edition present a comprehensive evaluation of the insulin therapy approaches, with an emphasis on insulin delivery strategies and current advances in engineered insulin delivery systems such as nano\/microcarriers and hydrogels. Chapters provides an overview of diabetes mellitus, cover technological innovations, explore artificial intelligence and machine learning approaches to manage diabetes, explore a wide range of non-invasive and alternative routes of insulin administration, and much more. Other chapters cover challenges and strategies in oral insulin delivery, the experimental techniques used to develop oral insulin carriers, the use of polymeric nano and microparticles for insulin delivery, and the use of lipids and inorganic nanoparticles in insulin delivery. The final chapter provide an overview of current clinical trials on insulin delivery and future perspectives in the area. Clinicians can benefit from this information to develop a clear understanding about the research carried out worldwide in the field of oral delivery of insulin, including those in the clinical phase. Covers AI\/ML-based tools and devices in diabetes management Explores noninvasive routes of insulin delivery and techniques\/approaches for maximizing bioavailability Discusses different delivery systems and approaches intended to increase the oral bioavailability of insulin\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537495404785,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443302725.jpg?v=1786384555"},{"product_id":"crude-drugs-of-unani-medicine","title":"Crude Drugs of Unani Medicine","description":"\u003cp\u003eby Shaikh Ajij Ahmad Makbul (ed.), Shamim Irshad Azmi (ed.), Mohd. Sayeed Akhtar (ed.) This novel two-volume compilation presents scientific knowledge pertaining to the utilization of crude drugs, encompassing data on pharmacology and phytochemistry, ethnomedical applications, as well as the influence of adulterants and substitutes on human health for the prevention, treatment, and management of diseases. Volume 1: Application and Utility for Human Welfare explores both the theoretical and practical aspects of potential medicinal plants and their bioactive compounds, either used individually or in combination within drug formulations, to combat a broad spectrum of chronic ailments, such as skin diseases, liver disorders, musculoskeletal conditions, reproductive system dysfunctions, immunological aberrations, and various other health issues. Volume 2: Phytochemistry and Pharmacology Aspects provides a comprehensive understanding of the pharmacology, phytochemistry, and pharmacovigilance of medicinal plants utilized in the traditional Unani system of medicine. It discusses the extensive range of possibilities presented by traditional medicine that enables the utilization of potential therapeutic agents in the form of standardized extracts, in conjunction with other herbs or as isolated bioactive constituents. These agents possess diverse properties such as antiparasitic, antifungal, antiviral, antibacterial, antioxidant, and anticancer activities, which can be utilized as drug treatments for various systemic disorders.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537495535857,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781998511983.jpg?v=1786384556"},{"product_id":"nanotherapeutics-in-the-treatment-of-reproductive-disorders","title":"Nanotherapeutics in the Treatment of Reproductive Disorders","description":"\u003cp\u003eby Younis Ahmad Hajam (ed.), Seema Rai (ed.) This new book delves into the transformative impact of nanotechnology on reproductive health challenges, exploring innovative solutions for disorders with profound societal implications and deepening our understanding of how nanotherapeutics can revolutionize the diagnosis, prevention, and treatment of reproductive disorders, opening new avenues for personalized interventions. Key features: Offers comprehensive coverage of current research and advancements in nanotherapeutics for reproductive disorders Provides in-depth analysis of the potential benefits and limitations of nanotherapeutics compared to traditional treatments for reproductive disorders Presents case studies and real-world examples of successful applications of nanotherapeutics for reproductive disorders Provides practical information and guidance for clinicians and researchers on how to develop and implement nanotherapeutic treatments for reproductive disorders\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537496060145,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781779640086.jpg?v=1786384557"},{"product_id":"crude-drugs-of-unani-medicine-2-volume-set","title":"Crude Drugs of Unani Medicine: 2-volume set","description":"\u003cp\u003eby Shaikh Ajij Ahmad Makbul (ed.), Shamim Irshad Azmi (ed.), Mohd. Sayeed Akhtar (ed.) This novel two-volume compilation presents scientific knowledge pertaining to the utilization of crude drugs, encompassing data on pharmacology and phytochemistry, ethnomedical applications, as well as the influence of adulterants and substitutes on human health for the prevention, treatment, and management of diseases. Crude Drugs in Unani Medicine is divided into two volumes, with the first volume exploring both the theoretical and practical aspects of potential medicinal plants and their bioactive compounds, either used individually or in combination within drug formulations, to combat a broad spectrum of chronic ailments, such as skin diseases, liver disorders, musculoskeletal conditions, reproductive system dysfunctions, immunological aberrations, and various other health issues. The second volume focuses on the pharmacology and phytochemistry of medicinal plants and animal-derived drugs, along with their pharmacovigilance. Crude Drugs of Unani Medicine: Volume 1: Application and Utility for Human Welfare delves into the understanding and application of Unani medicine (formerly referred to as Greco-Arab medicine) as a means of cure, rehabilitation, and promotion of human well-being. In the present day, medicinal plants or their bioactive compounds provide a multitude of possibilities within the Unani system of medicine. This serves as a fundamental framework, employing rational scientific theories and holistic concepts of health and healing to ensure safe diagnostic and therapeutic methods. The vast array of chemical and structural properties exhibited by medicinal plants has also been bolstered by the evolution of crude drugs, which can be utilized individually or in combination to promote human well-being. Crude Drugs of Unani Medicine: Volume 2: Phytochemistry and Pharmacology Aspects provides a comprehensive understanding of the pharmacology, phytochemistry, and pharmacovigilance of medicinal plants utilized in the traditional Unani system of medicine. The extensive range of possibilities presented by traditional medicine enables the utilization of potential therapeutic agents in the form of standardized extracts, in conjunction with other herbs or as isolated bioactive constituents. These agents possess diverse properties such as antiparasitic, antifungal, antiviral, antibacterial, antioxidant, and anticancer activities, which can be utilized as drug treatments for various systemic disorders. Moreover, these treatments have a positive impact on human health and are considered safe for consumption. Together, these two esteemed volumes offer a comprehensive resource on the use and administration of Unani drugs for diverse medical ailments. The valuable information provided here can enhance human immunity against a range of medical conditions while also avoiding undesirable side effects.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537496551665,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781998511945.jpg?v=1786384558"},{"product_id":"mucosal-vaccine-delivery-systems-the-future-of-immunization-part-2","title":"Mucosal Vaccine Delivery Systems: The Future of Immunization (Part 2)","description":"\u003cp\u003eby Shaweta Sharma, Aftab Alam (ed.), Akhil Sharma (ed.) Continuing on the groundbreaking discussion on next-generation mucosal vaccines, Mucosal Vaccine Delivery Systems: The Future of Immunization – Part II highlights innovations that redefine preventive healthcare and immunotherapy. By integrating research insights with translational applications, this volume examines the latest progress in mucosal delivery routes, immunological responses, and technological advances that enhance vaccine stability, efficacy, and accessibility . The book draws on global expertise to explore nasal, oral, pulmonary, and urogenital vaccination systems, offering perspectives on formulation strategies, immune modulation, and delivery optimization. It also discusses evolving regulatory frameworks, emerging biotechnological tools, and the socioeconomic impact of widespread mucosal vaccine adoption. Key Features: -Examines advances in mucosal vaccine platforms and immune mechanisms. -Explores innovative delivery routes enhancing patient compliance and protection. -Addresses challenges in formulation, stability, and large-scale production. -Evaluates regulatory and commercial trends shaping vaccine deployment. -Highlights translational research bridging laboratory discovery and clinical application.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537497239793,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9798898810245-1.jpg?v=1786384560"},{"product_id":"the-digital-pillbox-integrating-ai-iot-and-pharma-solutions-part-2","title":"The Digital Pillbox: Integrating AI, IoT, and Pharma Solutions (Part 2)","description":"\u003cp\u003eby Akhil Sharma, Neeraj Fuloria (ed.), Pankaj  Singh (ed.), Shaweta Sharma (ed.) Building on the foundations of Part 1, this volume explores advanced integrations of AI, IoT, and data-driven systems in pharmaceutical logistics, drug lifecycle management, clinical trials, and personalized therapeutics. It emphasizes the emergence of connected ecosystems where devices, data, and decisions interact seamlessly to enhance drug delivery, traceability, and compliance. Chapters cover critical topics such as digital drug development, AI-enabled pharmacovigilance, remote patient monitoring, blockchain-secured supply chains, and ethical frameworks for digital pharma solutions. The book also addresses the challenges of interoperability, cybersecurity, and adapting to global healthcare standards. Key Features: -Analyze advanced applications of AI and IoT across the pharmaceutical value chain. -Examine digital transformation in clinical trials, drug tracking, and e-prescriptions. -Present case studies on AI-driven decision support and blockchain in pharma logistics. -Discuss regulatory compliance, cybersecurity, and ethical considerations. -Explore future trends in connected healthcare and smart medication ecosystems.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537497927921,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9798898810696-1.jpg?v=1786384562"},{"product_id":"clinical-manual-of-addiction-psychopharmacology-3rd-edition","title":"Clinical Manual of Addiction Psychopharmacology, 3rd Edition","description":"\u003cp\u003eby M.T.S. Jeffrey DeVido, M.D., M.D. Carla Marienfeld, M.D. Henry R. Kranzler, M.A. Petros Levounis, M.D. Global challenges—public health crises, climate change, racial and socioeconomic tensions—have intensified the substance use and overdose epidemic. The Clinical Manual of Addiction Psychopharmacology, now in its third edition, asserts that substance misuse and addictive disorders, despite their complex origins, are treatable conditions. Revised for the first time in a decade, this manual is filled with the latest scientific advancements and practical guidance for today's addiction psychiatry and medicine workforce. Organized by substance class, it offers quick access to essential information. New chapters in this volume discuss social and systemic perspectives on pharmacotherapy; emerging treatments for non-substance-related addictive disorders such as gambling; nonstandard pharmacotherapies, including herbal supplements; and interventional treatments such as transcranial magnetic stimulation. Every chapter reflects the evolving social and clinical landscape, focusing on the current state of research and clinical treatment recommendations. The Clinical Manual of Addiction Psychopharmacology remains an essential resource for all those seeking to support the clinical needs of their patients and communities.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537498419441,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781615374465.jpg?v=1786384563"},{"product_id":"ai-and-drug-development-opportunities-privacy-and-challenges","title":"AI and Drug Development: Opportunities, Privacy and Challenges","description":"\u003cp\u003eby Shaik Aminabee, Atmakuri Lakshmana Rao This important book shines a light on the potential benefits of artificial intelligence (AI) to support advances in drug discovery and development, while also highlighting critical issues around patient confidentiality and ethical practice. In an era of rapid technological advancement, the book offers a comprehensive assessment of both the challenges and opportunities that AI offers the pharmaceutical sector, explaining how AI and machine learning can support the drug development research process. Illustrated with international case studies that demonstrate how these technologies have already been used to help develop new therapeutic possibilities, it also offers a discussion of ethical concerns around privacy and data protection. By thus taking into account both the technological and ethical issues of AI, the book seeks to present a fair and impartial perspective on the role of AI in further global healthcare. The book will interest to students and researchers across the Health Science, but particularly in Pharmacy, Pharmacology and related fields, as well as those concerned with AI itself. It will also appeal to practicing pharmacists and pharmacologists working in drug research and development.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537498550513,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040652893-1.jpg?v=1786384565"},{"product_id":"long-acting-injectable-medications-in-mental-health","title":"Long-Acting Injectable Medications in Mental Health","description":"\u003cp\u003eby Megan J. Ehret Long-Acting Injectable Medications in Mental Health describes the currently available long-acting injectable (LAI) medications to treat mental health and substance use disorders. Each chapter details how the medication's LAI technology utilized by the formulation, the dosing parameters, including missed dosing, pharmacokinetic properties, drug interactions, adverse effects, and preparation and administration instructions. Additionally, each medication chapter describes the efficacy of the formulation in comparison to other LAIs and oral medications. The book provides insight into how to approach a patient to engage in a conversation regarding LAI options. Switching strategies between agents and discontinuation options for patients are also included. Clinical pearls and tips on the role of these medications in clinical practice are provided to assist providers and pharmacists with the selection of agents and best practices regarding their use. A chapter is devoted to the use of LAIs in special populations (pregnant and lactating patients, older adults, pediatrics). The book is unique in that it encompasses all aspects of LAIs, from conversation to selection to administration and beyond. As this marketplace continues to increase, LAIs are becoming a mainstay of therapy for those with serious mental illness and substance use disorders. This book highlights the differences in products and the importance of understanding these differences to have the best outcome for the patient. Many providers are not familiar or comfortable with these formulations, but this book provides pharmacists and other healthcare providers, who are positioned to discuss these options with patients, with a highly accessible and comprehensive resource.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537499205873,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9783032094155.jpg?v=1786384567"},{"product_id":"artificial-intelligence-for-drug-design","title":"Artificial Intelligence for Drug Design","description":"\u003cp\u003eby Honglin Li (ed.), Mingyue Zheng (ed.), Feng Zhu (ed.), Fang Bai (ed.) This book focuses on the application of artificial intelligence in drug research and development, particularly its growing role in evaluating interactions between biological targets and drug molecules and optimizing drug design pathways. It offers a comprehensive structure divided into four parts: fundamentals of AI algorithms, data foundations and representations, AI driven drug design, and program code. The book systematically introduces key AI methodologies, highlights essential biomedical data resources, and presents data mining approaches based on artificial intelligence. Following the workflow of drug R\u0026amp;D, each chapter explains the basic principles and challenges of specific drug design steps and then reviews the corresponding advances in AI algorithms, supplemented by cross-disciplinary application examples. Readers will gain a clear understanding of how AI integrates into and accelerates the drug development process while reducing associated risks and costs, making the book particularly valuable for researchers and technical professionals engaged in life sciences and pharmaceutical R\u0026amp;D.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537499697393,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9789819525256.jpg?v=1786384568"}],"url":"https:\/\/pharmalibrary.online\/collections\/general-pharmacology.oembed?page=4","provider":"Pharma","version":"1.0","type":"link"}